Suzhou Ribo Life Science Co., Ltd. (SEHK: 6938)
Health Care · Biotechnology · CN
HK$55.90
+2.95% today · -31.9% 1Y
Suzhou Ribo Life Science Co., Ltd. (SEHK: 6938) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.21B and employs 453 people.
Over the last twelve months the share price has lost 31.9%, trading between 43.60 and 95.80.
Tweenvest scores Suzhou Ribo Life Science Co., Ltd. across four factors: quality 27/100, value 56/100. Its strongest factor is value.
6938 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.21B
- Revenue (TTM)
- $68.37M
- P/E
- —
- EPS
- -1.12
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$95.80
- 52-week low
- HK$43.60
- Avg volume (3M)
- —
- Shares outstanding
- 170.55M
- Employees
- 453
- Next earnings
- —
About Suzhou Ribo Life Science Co., Ltd.
Suzhou Ribo Life Science Co., Ltd. researches and develops novel therapeutics for the treatment of cardiovascular, metabolic, renal, and liver diseases in Chinese mainland and internationally. It develops RBD4059, which is phase 2 clinical trial for treating thrombotic diseases; RBD5044 that is in phase 2 clinical trial for treating hypertriglyceridemia; RBD7022, which is in phase 2 clinical trial for the treatment of hypercholesterolemia; RBD7007 and RBD2080 that are in Phase I clinical trial for the treatment of renal diseases. Suzhou Ribo Life Science Co., Ltd. was incorporated in 2007 and is based in Kunshan, China.
- ISIN
- CNE100007DS6
- Founded
- 2007
- Listed since
- Jan 9, 2026
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Replimune Group, Inc.NasdaqGS: REPL | $1.26B | $13.42 | +2.68% |
| Daan Gene Co., Ltd.SZSE: 002030 | $1.26B | CN¥6.03 | +4.87% |
| Savara Inc.NasdaqGS: SVRA | $1.25B | $4.92 | +1.86% |
| ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC | $1.24B | $11.99 | -1.76% |
| Nanobiotix S.A.ENXTPA: NANO | $1.21B | €21.24 | +3.51% |
| Bio-Thera Solutions, Ltd.SHSE: 688177 | $1.19B | CN¥19.30 | -8.23% |
| BioGaia AB (publ)OM: BIOG B | $1.18B | Skr116.80 | +1.21% |
| Vor Biopharma Inc.NasdaqGS: VOR | $1.18B | $19.90 | +6.47% |
Figures last refreshed Oct 11, 2026.